IRLAB Therapeutics AB (publ) (IRLAB-A) — Financial Flexibility Index
IRLAB Therapeutics AB (publ) (IRLAB-A) has a Financial Flexibility Index of -0.22x as of December 2025. Free cash flow of Skr-24.18 Million (operating CF Skr-24.18 Million minus capex Skr0.00) represents 0% of total liabilities (Skr107.49 Million). Check IRLAB-A capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
IRLAB Therapeutics AB (publ) Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for IRLAB Therapeutics AB (publ) across 12 annual periods. See working capital to net assets of IRLAB Therapeutics AB (publ) to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for IRLAB Therapeutics AB (publ) (2014–2025)
Year-by-year free cash flow to debt coverage for IRLAB Therapeutics AB (publ). For the full company profile including market capitalisation, see how much is IRLAB Therapeutics AB (publ) worth.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.51x | Skr-55.22 Million | Skr-55.22 Million | Skr107.49 Million | ▲ +18.6% |
| 2024 | -0.63x | Skr-65.39 Million | Skr-65.59 Million | Skr103.58 Million | ▲ +76.5% |
| 2023 | -2.68x | Skr-164.56 Million | Skr-164.85 Million | Skr61.36 Million | ▲ +37.0% |
| 2022 | -4.25x | Skr-139.24 Million | Skr-142.61 Million | Skr32.72 Million | ▼ -340.0% |
| 2021 | 1.77x | Skr129.35 Million | Skr128.64 Million | Skr72.97 Million | ▲ +144.3% |
| 2020 | -4.00x | Skr-88.82 Million | Skr-89.21 Million | Skr22.19 Million | ▼ -15.3% |
| 2019 | -3.47x | Skr-91.06 Million | Skr-91.20 Million | Skr26.24 Million | ▲ +38.0% |
| 2018 | -5.60x | Skr-69.74 Million | Skr-70.79 Million | Skr12.46 Million | ▲ +22.4% |
| 2017 | -7.22x | Skr-57.52 Million | Skr-57.74 Million | Skr7.97 Million | ▼ -63.9% |
| 2016 | -4.40x | Skr-40.60 Million | Skr-40.82 Million | Skr9.22 Million | ▼ -44.3% |
| 2015 | -3.05x | Skr-27.66 Million | Skr-27.66 Million | Skr9.06 Million | ▼ -394.1% |
| 2014 | -0.62x | Skr-11.02 Million | Skr-11.02 Million | Skr17.86 Million | — |